University of California San Francisco, Fresno, California, USA.
Fresno, California, USA.
Clin Pharmacol Ther. 2018 Sep;104(3):458-469. doi: 10.1002/cpt.1097. Epub 2018 Jun 19.
The use of botanicals, often in the form of multi-ingredient herbal dietary supplements (HDS), has grown tremendously in the past three decades despite their unproven efficacy. This is paralleled by an increase in dietary supplement-related health complications, notably hepatotoxicity. This article reviews the demographics and motivations of dietary supplement (DS) consumers and the regulatory framework for DS in the US and other developed countries. It examines in detail three groups of multi-ingredient HDS associated with hepatotoxicity: OxyElite Pro (two formulations), green tea extract-based DS, and "designer anabolic steroids." These examples illustrate the difficulties in identifying and adjudicating causality of suspect compound(s) of multi-ingredient HDS-associated liver injury in the clinical setting. The article outlines future directions for further study of HDS-associated hepatotoxicity as well as measures to safeguard the consumer against it.
尽管植物药(通常以多种草药为成分的膳食补充剂形式)的疗效未经证实,但在过去三十年中,其使用量却大幅增加。与之相伴的是,膳食补充剂相关的健康并发症显著增加,特别是肝毒性。本文综述了膳食补充剂消费者的人口统计学特征和动机,以及美国和其他发达国家对膳食补充剂的监管框架。本文详细研究了三组与肝毒性相关的多种草药为成分的膳食补充剂:OxyElite Pro(两种配方)、含绿茶提取物的膳食补充剂和“设计型合成代谢类固醇”。这些例子说明了在临床环境中,确定和裁定多种草药为成分的膳食补充剂相关肝损伤中可疑化合物因果关系的困难。本文概述了进一步研究多种草药为成分的膳食补充剂相关肝毒性的未来方向,以及保护消费者免受其害的措施。